BetterLife Pharma Financial Overview
BetterLife Pharma's market cap is currently $5.52M. The company's EPS TTM is $-0.002179986; its P/E ratio is -9.02; BetterLife Pharma is scheduled to report earnings on September 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
